Randall Mack, Senior VP, Development at Recro Pharma, Inc. (REPH), bought 2,000 shares at $6.30 ($13K) on 2016-05-23, disclosed to the SEC on 2016-05-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.